AACR Annual Meeting 2026
April 17–22, 2026 · San Diego · 2418 items
Over 22,000 attendees and more than 7,400 abstracts, including a record 265 clinical trial abstracts. This section collects on-site analysis across fifteen signal directions, plus late-breaking, clinical-trial and new-drug abstracts.
Page 2 No.21–40
Participants · trend · heat index- 21
#LIQUIDBIOPSIESBuilding
10↑ 512%10↑ 512% - 22
atezolizumabBuilding
10↑ 9900%10↑ 9900% - 23
#ONCORADBuilding
10↑ 371%10↑ 371% - 24
#SCLC
10↓ 29%10↓ 29% - 25
#HIFISEQUENCING
10↓ 29%10↓ 29% - 26
#HNSCC
9↓ 29%9↓ 29% - 27
#SUTROBIOBuilding
9↑ 2867%9↑ 2867% - 28
#SCIENCEWEBINARSBuilding
9↑ 889%9↑ 889% - 298↓ 29%
- 30
#GYNCSMBuilding
8↑ 3700%8↑ 3700% - 31
TROP2
7↓ 29%7↓ 29% - 32
zoldonrasib
7↓ 29%7↓ 29% - 33
enfortumab
7↓ 29%7↓ 29% - 34
sotorasib
7↓ 29%7↓ 29% - 35
#GASTROESOPHAGEALCANCER
7↓ 29%7↓ 29% - 36
pembrolizumab
7↓ 30%7↓ 30% - 37
#MEDICINE
7↓ 30%7↓ 30% - 38
CLDN18
7↓ 29%7↓ 29% - 39
nivolumab
7↓ 29%7↓ 29% - 40
#LIQUIDBIOPSY
7↓ 29%7↓ 29%